OJEMDA
Live / Registered — Registered (as of 22 Jul 2025)
What this means for you
Registered since 22 Jul 2025. The owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 98030463
- Registration number
- 7871167
- Mark type
- Stylized text
- Filed
- 06 Jun 2023
- Published for opposition
- 09 Jul 2024
- Registered
- 22 Jul 2025
- Attorney of record
- Connie L. Ellerbach
Goods and services
- Class 005 — Pharmaceuticals: Pharmaceutical preparations for human use for the treatment of cancer; pharmaceutical preparation for the prevention and treatment of cancer; pharmaceutical preparations for the treatment of oncological diseases; pharmaceutical preparations and substances for the prevention and treatment of oncological diseases and disorders; targeted pharmaceutical preparations for use in the field of cancer prevention and treatment; pharmaceutical preparations for the delivery of compounds to the body for the treatment and prevention of oncological related diseases and disorders
- Class 042 — Scientific and technological services: Research, development, and product evaluation of pharmaceutical preparations for the prevention and treatment of cancer; laboratory analysis and research of drugs and pharmaceutical products; research and development services in the fields of oncology, immunotherapy, chemotherapy, and combination therapies for the treatment of cancer and tumors; providing medical research information in the fields of oncology, immunotherapy, chemotherapy and combination therapies; scientific advisory services, namely, providing scientific information, advice, and consultancy in the field of cancer treatment; design, development, research, and testing of new products, namely, drugs and pharmaceuticals for the treatment and/or prevention of oncological diseases and disorders
- Class 044 — Medical, beauty and agricultural services: Medical information services; healthcare services, namely, providing cancer treatment information to physicians, health care professionals, and patients; medical information services, namely, providing information regarding oncological diseases and disorders
Owner
- Day One Biopharmaceuticals, Inc., Brisbane, CA, US
- Day One Biopharmaceuticals, Inc., Brisbane, CA, US
- Day One Biopharmaceuticals, Inc., Brisbane, CA, US
Prosecution history
- 22 Jul 2025 — NOTICE OF REGISTRATION CONFIRMATION EMAILED
- 22 Jul 2025 — REGISTERED-PRINCIPAL REGISTER
- 16 Jul 2025 — NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
- 27 Jun 2025 — ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
- 21 May 2025 — STATEMENT OF USE PROCESSING COMPLETE
- 27 Feb 2025 — USE AMENDMENT FILED
- 22 May 2025 — CASE ASSIGNED TO INTENT TO USE PARALEGAL
- 28 Feb 2025 — TEAS STATEMENT OF USE RECEIVED
- 10 Jan 2025 — TEAS CHANGE OF CORRESPONDENCE RECEIVED
- 10 Jan 2025 — APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
- 10 Jan 2025 — TEAS CHANGE OF OWNER ADDRESS RECEIVED
- 03 Sept 2024 — NOA E-MAILED - SOU REQUIRED FROM APPLICANT
- 09 Jul 2024 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
- 09 Jul 2024 — PUBLISHED FOR OPPOSITION
- 19 Jun 2024 — NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED